Filing Details

Accession Number:
0001104659-21-099741
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-04 06:06:25
Reporting Period:
2021-08-03
Accepted Time:
2021-08-04 06:06:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1790340 Immuneering Corp IMRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1870062 J. Benjamin Zeskind C/O Immuneering Corporation,
245 Main Street, Second Floor
Cambridge MA 02142
President And Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-08-03 49,099 $0.00 2,598,171 No 4 C Direct
Class A Common Stock Acquisiton 2021-08-03 2,098 $15.00 2,600,269 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Series A Preferred Stock Disposition 2021-08-03 40,928 $0.00 40,928 $0.00
Class A Common Stock Series B Preferred Stock Disposition 2021-08-03 8,171 $0.00 8,171 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class A Common Stock 544,927 Indirect See Foonote
Footnotes
  1. Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis.
  2. Held by the Benjamin J. Zeskind 2020 Family Trust, where Lisa Schwartz, Dr. Zeskind's spouse, serves as sole trustee.